(Q63319730)
Statements
Randomized, Double-Blind, Placebo-Controlled Trial if IL1-TRAP, Rilonacept, in Systemic Sclerosis -A Phase I/II Biomarker Trial (English)
0 references
December 2011
0 references
January 2017
0 references
24
0 references
18 year
0 references